Skip to main content
. 2022 Jun 28;61(9):1271–1284. doi: 10.1007/s40262-022-01139-w

Table 2.

Plasma concentration-time profiles

A is plasma concentration-time profiles after single dose of upacicalcet
Step Group N Cmax (ng/mL) tmax (h) AUC0–66h (h·ng/mL) AUCinf (h·ng/mL) t1/2 (h) MRT0–t (h) MRTinf (h) CLp (mL/h) Vdss (mL)
Step 1 0.025 mg 4 3.20 ± 0.86 0.167 ± 0.000 85.1 ± 8.21 270 ± 161 122 ± 80.7 29.2 ± 0.250 174 ± 113 106 ± 43.5 14900 ± 741
Step 2 0.05 mg 4 6.93 ± 1.62 0.167 ± 0.000 203 ± 26.6 456 ± 63.3 77.6 ± 8.87 28.8 ± 0.386 111 ± 12.2 105 ± 13.5 11700 ± 1710
Step 3 0.1 mg 4 10.5 ± 3.79 0.375 ± 0.417 261 ± 81.8 506 ± 235 65.0 ± 30.6 26.8 ± 2.83 91.5 ± 44.8 211 ± 71.5 17700 ± 7990
Step 4 0.2 mg 4 21.9 ± 2.61 0.167 ± 0.000 675 ± 99.4 1480 ± 257 76.6 ± 8.08 28.6 ± 0.171 109 ± 11.3 130 ± 24.7 14100 ± 2060
Step 5 0.4 mg 4 56.5 ± 8.32 0.167 ± 0.000 1530 ± 320 3150 ± 1080 68.1 ± 14.1 28.1 ± 0.929 97.1 ± 20.7 129 ± 37.7 11900 ± 1530
Step 6 0.6 mg 4 74.2 ± 25.1 0.167 ± 0.000 2130 ± 542 5000 ± 1350 83.2 ± 6.88 29.1 ± 0.472 119 ± 9.42 120 ± 35.5 14200 ± 3960
Step 7 0.8 mg 5 113 ± 42.0 0.167 ± 0.000 2700 ± 1250 6130 ± 3530 72.0 ± 33.1 26.3 ± 6.23 102 ± 47.9 212 ± 224 13200 ± 4770
B is plasma concentration-time profiles after multiple dose of upacicalcet
Step Group Visit (day) N Ctrough (ng/mL) Cmax (ng/mL)
Step 1 0.05 mg 1 8 7.10 ± 1.84
3 8 2.21 ± 0.97
5 8 2.42 ± 1.20
8 8 1.97 ± 1.17
10 8 2.66 ± 1.23
12 8 2.46 ± 1.45
15 7 2.04 ± 1.41
17 7 2.67 ± 1.25 7.83 ± 1.43
19 7 2.84 ± 1.28
22 7 1.88 ± 1.17
Step 2 0.1 mg 1 8 15.6 ± 4.21
3 8 5.19 ± 1.02
5 8 6.43 ± 1.10
8 8 5.49 ± 1.24
10 8 6.56 ± 1.24
12 7 6.60 ± 1.29
15 7 5.38 ± 1.27
17 6 6.61 ± 0.82 16.7 ± 3.35
19 6 6.52 ± 1.15
22 6 5.68 ± 1.01 ±
Step 3 0.2 mg 1 10 26.3 ± 4.73
3 10 8.65 ± 1.98
5 10 10.7 ± 2.78
8 9 8.88 ± 2.83
10 9 10.5 ± 2.52
12 7 11.2 ± 3.69
15 7 9.17 ± 3.12
17 7 11.2 ± 3.35 26.4 ± 7.15
19 6 10.5 ± 3.21
22 4 11.1 ± 2.90

Mean ± SD